2024 Annual Meeting | H104 - Lessons Learned from Multi-center Trial Submission (Research Hub)

Date Monday 04/15/24

Time 01:00 PM - 01:30 PM MDT Add To Calendar

Location Colorado Convention Center | Exhibit Hall B-E

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Research)

Director(s) Gregory S. Day, MD, MSc, FAAN

Topic(s) General Neurology, Education, Research, and Methodology

Learning Objectives Submitting a multi-center trial grant can be time consuming and confusing. This interactive session will offer practical tips and solutions for trial submission, based on the presenter's personal experience developing, opening, and conducting the NIH-funded ExTINGUISH Trial for NMDAR encephalitis.

CME Available No CME available

Core Competencies Medical Knowledge, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Neurohospitalist, Coordinator

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:30 PM MDT	Speaker	Lessons Learned from Multi-center Trial Submission Gregory S. Day, MD, MSc, FAAN

Faculty Disclosures
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.